JAK2 V617F binds to, and stimulates, all three receptors involved in the pathogenesis of MPN erythropoietin receptor (EPOR), TPOR and granulocyte-colony stimulating factor receptor (G-CSFR). Here, JAK2 is linked to myeloproliferative neoplasm.